Destina Genomics secures investment from the Scottish Investment Bank.

Glow has secured $17m in a series B round featuring Formation 8, Founder's Fund and Andreessen Horowitz in order to help develop and expand its fertility tracking app.

Pharmaceutical firm UCB invested $7.5m as the dermatology company floated at the top of its range.

FibroGen, a Astellas-backed biotech firm, is lining up a $125m initial public offering to raise money for further drug development.

Shares in the company drop to yet another new time low.

Pharmaceutical companies Eli Lilly and Bukwang Pharma were among the backers of venture firm TVM's latest fund, which closed at $201.6m.

The Alzheimer's disease testing company has raised a round backed by Alopexx and Nestle's corporate venturing unit.

A $250m investment by Kuwait Investment Authority helped close the round, adding to funds provided by Celgene in June.

Durham University will receive direct investments as part of the acquisition deal.

Private clinical stage company Pulmologix has received $12m in a Novo-backed series B round to explore new medical approaches to treat respiratory disease.